Have a feature idea you'd love to see implemented?
Let us know!
PODD Insulet Corp
Price (delayed)
$262
Market cap
$18.38B
P/E Ratio
43.52
Dividend/share
N/A
EPS
$6.02
Enterprise value
$18.87B
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod
Highlights
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2662.1 and 12% lower than its last 4 quarters average of 49.7
The equity has soared by 84% YoY and by 12% QoQ
Key stats
What are the main financial stats of PODD
Market
Valuations
Earnings
Shares outstanding
70.14M
Market cap
$18.38B
Enterprise value
$18.87B
Price to earnings (P/E)
43.52
Price to book (P/B)
16.43
Price to sales (P/S)
9.26
EV/EBIT
55.94
EV/EBITDA
45.42
EV/Sales
9.51
Revenue
$1.98B
EBIT
$337.4M
EBITDA
$415.5M
Free cash flow
$193.1M
Per share
Balance sheet
Liquidity
EPS
$6.02
Free cash flow per share
$2.75
Book value per share
$15.95
Revenue per share
$28.29
TBVPS
$40.99
Total assets
$3.03B
Total liabilities
$1.91B
Debt
$1.4B
Equity
$1.12B
Working capital
$1.35B
Debt to equity
1.25
Current ratio
3.68
Quick ratio
2.53
Net debt/EBITDA
1.19
Margins
Efficiency
Dividend
EBITDA margin
20.9%
Gross margin
69.4%
Net margin
21.2%
Operating margin
15.4%
Return on assets
15.1%
Return on equity
46.3%
Return on invested capital
12.2%
Return on capital employed
13.4%
Return on sales
17%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PODD stock price
How has the Insulet stock price performed over time
Intraday
-1.72%
1 week
0.32%
1 month
10.79%
1 year
44.5%
YTD
20.75%
QTD
12.57%
Financial performance
How have Insulet's revenue and profit performed over time
Revenue
$1.98B
Gross profit
$1.38B
Operating income
$306M
Net income
$420.9M
Gross margin
69.4%
Net margin
21.2%
The company's net margin has surged by 175% YoY
Insulet's operating income has surged by 123% YoY and by 12% QoQ
The company's operating margin has surged by 75% YoY and by 5% QoQ
PODD's gross profit is up by 35% YoY and by 6% from the previous quarter
Growth
What is Insulet's growth rate over time
Valuation
What is Insulet stock price valuation
P/E
43.52
P/B
16.43
P/S
9.26
EV/EBIT
55.94
EV/EBITDA
45.42
EV/Sales
9.51
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2662.1 and 12% lower than its last 4 quarters average of 49.7
The EPS has grown by 7% from the previous quarter
The equity has soared by 84% YoY and by 12% QoQ
PODD's price to book (P/B) is 62% less than its 5-year quarterly average of 42.7
PODD's price to sales (P/S) is 33% lower than its 5-year quarterly average of 13.8 but 17% higher than its last 4 quarters average of 7.9
PODD's revenue is up by 27% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Insulet business performance
The return on assets has surged by 196% year-on-year
PODD's ROE has soared by 107% YoY but it is down by 8% QoQ
Insulet's return on invested capital has surged by 85% YoY and by 8% QoQ
The ROS has soared by 59% YoY and by 3.7% from the previous quarter
Dividends
What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PODD.
Financial health
How did Insulet financials performed over time
The total assets is 59% higher than the total liabilities
The total assets rose by 23% YoY and by 5% QoQ
Insulet's quick ratio has increased by 19% YoY and by 5% from the previous quarter
The company's debt is 25% higher than its equity
The equity has soared by 84% YoY and by 12% QoQ
The debt to equity has decreased by 47% YoY and by 11% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.